Leonidaz Pharmaceuticals Private Limited, a active private limited company, was established on 28 September 2005 in Tirur, Kerala, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232KL2005PTC018671. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹4.60 M and a paid-up capital of ₹4.60 M.
It upholds a compliant status. Employing 20 professional, Its leadership includes Mechery Chandran Jayaprakash (Managing Director), Mechery Manoj Kumar Chandran (Director), Moosari Parambil Ramesh (Director). Past directors included Geetha Thekkat Madhavamenon. It holds ₹5.50 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 19/89A Rasiya Building Opposite Civil Station, Tirur, Kerala, 676101.
U24232KL2005PTC018671
018671
28 September 2005
₹4.60 M
₹4.60 M
Roc Ernakulam
Unlisted
Active
Explore comprehensive insights into Leonidaz Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mechery Chandran Jayaprakash | Managing Director | 28 Sep 2005 | Current |
| Mechery Manoj Kumar Chandran | Director | 28 Sep 2005 | Current |
| Moosari Parambil Ramesh | Director | 28 Sep 2005 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Jul 2009 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Leonidaz Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 15.21% decrease. The company also saw a substantial fall in profitability, with a 65.21% decrease in profit. The company's net worth Soared by an impressive increase of 375.07%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Leonidaz Pharmaceuticals had a promoter holding of 91.64% and a public holding of 8.36%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹5,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Aug 2006 | Canara Bank | ₹5.50 M | Open |
Explore comprehensive loan charge details -
Leonidaz Pharmaceuticals has a workforce of 20 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Leonidaz Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Leonidaz Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Canara Bank of Rs. 5.50 M registered on 10 Aug 2006 with Charge ID 10016028 was modified on 20 Feb 2025. was documented.
The activity Leonidaz Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Leonidaz Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam. was documented.
Progress on A charge with Canara Bank amounted to Rs. 5.50 M with Charge ID 10016028 was registered on 10 Aug 2006. was documented.
Mechery Chandran Jayaprakash was appointed as a Managing Director was appointed as a Managing Director on 28 Sep 2005 & has been associated with this company since 20 years 3 months . was recorded as a recent event.
Mechery Manoj Kumar Chandran was appointed as a Director was appointed as a Director on 28 Sep 2005 & has been associated with this company since 20 years 3 months . was recorded as a recent event.
The CIN of Leonidaz Pharmaceuticals Private Limited is U24232KL2005PTC018671.
Leonidaz Pharmaceuticals Private Limited is headquartered at 19/89A Rasiya Building Opposite Civil Station, Tirur, Kerala, 676101.
Leonidaz Pharmaceuticals Private Limited was incorporated on 28 September 2005.
The current directors of Leonidaz Pharmaceuticals Private Limited are
The primary industry of Leonidaz Pharmaceuticals Private Limited is Manufacturing.
Leonidaz Pharmaceuticals Private Limited is unlisted.
The authorized capital of Leonidaz Pharmaceuticals Private Limited is ₹4.60 M, and the paid-up capital is ₹4.60 M.
The compliance status of Leonidaz Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX